Navigation Links
FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over
Date:2/11/2008

BOSTON, Feb. 11 /PRNewswire/ -- Replikins Ltd. announced that the quantitative analysis of Replikin Count(TM) in the virus gene structure predicts that the current H5N1 cycle is over. Sporadic outbreaks may continue, but the rapid epidemic spread and high mortality characteristics are expected to subside - until the next rapid replication cycle of this or another influenza virus strain begins.

140,000 virus protein sequences were analyzed by FluForecast(R) software in this study. A key gene, the Replikin Peak Gene, was found to contain the highest concentration of replikins in the virus genome. In H5N1 reservoirs in chickens, the Replikin Count(TM) has now decreased markedly, successively each year from 2004 to 2007. The Replikin count in human H5N1 also has decreased in the past year. All stated increases and decreases were statistically significant with a p value of less than 0.001.

The current H5N1 cycle of bird flu began in 1996 with a pre-symptomatic increase in the Replikin count, followed in 1997 by the Hong Kong outbreak, then by a decline in Replikin count in 1998-1999 with culling, followed by increases in the count in 2001 and 2004 providing advance warning of the further outbreaks which occurred in Asia. An increase in the Replikin count in human H5N1 in 2006 specifically predicted the increase in H5N1 lethality in humans, and that the first country to show this increase would be Indonesia. These predictions were proven correct in 2006-2007.

The last two influenza pandemics of 1957 (H2N2) and 1968 (H3N2), and the SARS outbreak of 2003, were also each preceded by an increase in the Replikin count, and in each case, a strain-specific decrease in the count several years later signaled that the cycle was over. Sporadic outbreaks of H3N2 for example have occurred thereafter, but the rapid epidemic spread and high mortality characteristics have not reappeared.

It has not been possible previously to predict in advance from changes in the structure of the virus the coming of epidemics or their cessation. This is now possible because of the discovery of the replikins, specific small peptide constituents of virus proteins whose concentration has been shown to be related quantitatively to rapid replication and epidemics.

FluForecast(R) is a product and service of Replikins Ltd. and Replikins, LLC, 38 The Fenway, Boston MA 02215. See also http://www.replikins.com.

Contact: sbogoch@replikins.com; Tel. 646-320-5910; 617-536-0220.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
2. DNA Predicts Reaction to Drug That Fights Alcohol Dependence
3. Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
4. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
5. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
8. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... ... Supplyframe, the Industry Network for electronics hardware design and ... in Pasadena, Calif., the Design Lab’s mission is to bring together inventors and ... brought to market. , The Design Lab is Supplyframe’s physical representation of one ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)... FRANCISCO , June 22, 2016  Amgen (NASDAQ: ... sponsorship of the QB3@953 life sciences incubator ... human health. The shared laboratory space at QB3@953 was ... overcome a key obstacle for many early stage organizations ... part of the sponsorship, Amgen launched two "Amgen Golden ...
(Date:6/22/2016)... ANGELES , June 22, 2016   StockNewsNow.com ... SNNLive Video Interview with Dr. Nader Pourhassan , ... biotechnology company focused on the clinical development and potential ... prevention of HIV infection, according to the company,s website ... recorded on Tuesday, June 7 th , 2016, at ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
Breaking Biology News(10 mins):